Potential treatments for COVID-19
As confirmed COVID-19 cases soar well past 3 million worldwide, the race is on to find treatments for patients as soon as possible.
The ‘G’ list: complementary medicines with bleeding risks
Many complementary medicines beginning with ‘G’ have been associated with a risk of bleeding that pharmacists should know.
Opioid pharmacotherapy: delivery in community pharmacy
The pharmacist’s guide to the different regulations and protocols across Australia.
Opioid substitution has been recognised globally as an effective harm minimisation strategy for...
How to talk patients’ language
Australia prides itself on its multicultural chemistry, but it presents everyday challenges. Community pharmacy services can play their part by catering specifically for people...
Active ingredient prescribing mandated
From 1 February 2021, medicines will be prescribed by active ingredient on all Pharmaceutical Benefits Scheme (PBS) prescriptions.
What’s happening in scope of practice around Australia?
There has been a lot of scope of practice changes and announcements. Here's a look at what's happening in your state/territory.
